RILDINADSTROCEL

UNII:	3ME9TTI5QB
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	RILDINADSTROCEL
GSRS Full Record:	3ME9TTI5QB i

ALLOGENEIC ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS (PSC-04)
ALLOGENIC ADIPOSE DERIVED MESENCHYMAL STEM CELLS (MSCS)
ALLOGENIC ADIPOSE DERIVED MESENCHYMAL STROMAL CELLS
ASTROSTEM-V
Allogeneic Adipose-Derived Mesenchymal stromal cells (AD-MSCs)
Astrostem-V [WHO-DD]
COVI-MSC is an allogeneic culture-expanded adipose-derived mesenchymal stem cells derived from a disease-screened donor’s adipose tissue collected via liposuction and which undergoes tissue processing and manufacturing of the cell product under Good Manufacturing Processes. The product undergoes various pathogen assessments and procedures to verify final product sterility including sterility by direct filtration, mycoplasma by polymerase chain reaction, and endotoxin evaluation. A maximum of 5 passages from the master cell bank (MCB) are used for culture expansion to maintain MSC viability
PSC-04
PSC-04 MCB
PSC-04 [WHO-DD]
RILDINADSTROCEL [USAN]
Rildinadstrocel
rildinadstrocel [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RILDINADSTROCEL

Synonyms and Mappings

Resources